Skip to content
PubMed This is a summary of 40 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 40 referenced papers

Top Authors

Marianna Bugiani
Amsterdam University Medical Centers
Colin Berry
Golden Jubilee National Hospital
Thomas Joseph Ford
Gosford Hospital
Naveed A. Sattar
British Heart Foundation
Anthony P. Davenport
University of Cambridge
Marjo S. van der Knaap
Emma Kinderziekenhuis
Sandosh Padmanabhan
British Heart Foundation
Josef Finsterer
Krankenanstalt Rudolfstiftung der Stadt Wien

Top Institutions

Ranked by publications Top 10 institutions
07

Emma Kinderziekenhuis

Amsterdam, The Netherlands

5 papers

References

References (40)
  1. 1

    Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol.

    Bocchetta M, Mega A, Bernardi L, et al.

    Journal of Alzheimer's disease : JAD 2016; (51(1)):277-91 doi:10.3233/JAD-150849.

    PMID: 26901402
  2. 2

    Interpretation of the evidence for the efficacy and safety of statin therapy.

    Collins R, Reith C, Emberson J, et al.

    Lancet (London, England) 2016; (388(10059)):2532-2561 doi:10.1016/S0140-6736(16)31357-5.

    PMID: 27616593
  3. 3

    Cathepsin A-related arteriopathy with strokes and leukoencephalopathy (CARASAL).

    Bugiani M, Kevelam SH, Bakels HS, et al.

    Neurology 2016; (87(17)):1777-1786 doi:10.1212/WNL.0000000000003251.

    PMID: 27664989
  4. 4

    European Society for Swallowing Disorders - European Union Geriatric Medicine Society white paper: oropharyngeal dysphagia as a geriatric syndrome.

    Baijens LW, Clavé P, Cras P, et al.

    Clinical interventions in aging 2016; (11()):1403-1428 doi:10.2147/CIA.S107750.

    PMID: 27785002
  5. 5

    Relationship between dysarthria and oral-oropharyngeal dysphagia: The current evidence.

    Wang BJ, Carter FL, Altman KW

    Ear, nose, & throat journal 2018; (97(3)):E1-E9.

    PMID: 29554404
  6. 6

    Updates on Prevention of Hemorrhagic and Lacunar Strokes.

    Tsai HH, Kim JS, Jouvent E, Gurol ME

    Journal of stroke 2018; (20(2)):167-179 doi:10.5853/jos.2018.00787.

    PMID: 29886717
  7. 7

    Advances in Vestibular Rehabilitation.

    Sulway S, Whitney SL

    Advances in oto-rhino-laryngology 2019; (82()):164-169 doi:10.1159/000490285.

    PMID: 30947180
  8. 8

    Update on hereditary, autosomal dominant cathepsin-A-related arteriopathy with strokes and leukoencephalopathy (CARASAL).

    Finsterer J, Scorza CA, Scorza FA, Wakil SM

    Acta neurologica Belgica 2019; (119(3)):299-303 doi:10.1007/s13760-019-01158-8.

    PMID: 31177426
  9. 9

    Fatal Intracerebral Hemorrhage in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL): A Case Report.

    Chiang CC, Christiansen ME, O'Carroll CB

    The neurologist 2019; (24(4)):136-138 doi:10.1097/NRL.0000000000000231.

    PMID: 31246723
  10. 10

    Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction.

    Ford TJ, Corcoran D, Padmanabhan S, et al.

    European heart journal 2020; (41(34)):3239-3252 doi:10.1093/eurheartj/ehz915.

    PMID: 31972008
  11. 11

    Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology.

    Mancuso M, Arnold M, Bersano A, et al.

    European journal of neurology 2020; (27(6)):909-927 doi:10.1111/ene.14183.

    PMID: 32196841
  12. 12

    Endothelin-1 signaling maintains glial progenitor proliferation in the postnatal subventricular zone.

    Adams KL, Riparini G, Banerjee P, et al.

    Nature communications 2020; (11(1)):2138 doi:10.1038/s41467-020-16028-8.

    PMID: 32358570
  13. 13

    Rationale and design of the Medical Research Council's Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial.

    Morrow AJ, Ford TJ, Mangion K, et al.

    American heart journal 2020; (229()):70-80 doi:10.1016/j.ahj.2020.07.007.

    PMID: 32942043
  14. 14

    Ethical Considerations on Pediatric Genetic Testing Results in Electronic Health Records.

    Kanungo S, Barr J, Crutchfield P, et al.

    Applied clinical informatics 2020; (11(5)):755-763 doi:10.1055/s-0040-1718753.

    PMID: 33176390
  15. 15

    Life Style and Behavioural Factors are Associated with Stroke Recurrence Among Survivors of First Episode of Stroke: A Case Control Study.

    Shani SD, Varma RP, Sarma PS, et al.

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2021; (30(4)):105606 doi:10.1016/j.jstrokecerebrovasdis.2021.105606.

    PMID: 33548808
  16. 16

    Diagnosis and treatment of neurogenic dysphagia - S1 guideline of the German Society of Neurology.

    Dziewas R, Allescher HD, Aroyo I, et al.

    Neurological research and practice 2021; (3(1)):23 doi:10.1186/s42466-021-00122-3.

    PMID: 33941289
  17. 17

    Patient and Relative Experiences and Decision-making About Genetic Testing and Counseling for Familial ALS and FTD: A Systematic Scoping Review.

    Crook A, Jacobs C, Newton-John T, et al.

    Alzheimer disease and associated disorders 2021; (35(4)):374-385 doi:10.1097/WAD.0000000000000458.

    PMID: 34054018
  18. 18

    Assessment of dysarthria and dysphagia in patients with amyotrophic lateral sclerosis: Review of the current evidence.

    Lee J, Madhavan A, Krajewski E, Lingenfelter S

    Muscle & nerve 2021; (64(5)):520-531 doi:10.1002/mus.27361.

    PMID: 34296769
  19. 19

    From Three-Months to Five-Years: Sustaining Long-Term Benefits of Endovascular Therapy for Ischemic Stroke.

    Ganesh A, Ospel JM, Marko M, et al.

    Frontiers in neurology 2021; (12()):713738 doi:10.3389/fneur.2021.713738.

    PMID: 34381418
  20. 20

    ESO Guideline on covert cerebral small vessel disease.

    Wardlaw JM, Debette S, Jokinen H, et al.

    European stroke journal 2021; (6(2)):CXI-CLXII doi:10.1177/23969873211012132.

    PMID: 34414301
  21. 21

    2021 Taiwan Stroke Society Guidelines of blood pressure control for ischemic stroke prevention.

    Chi NF, Chung CP, Cheng HM, et al.

    Journal of the Chinese Medical Association : JCMA 2022; (85(6)):651-664 doi:10.1097/JCMA.0000000000000738.

    PMID: 35507097
  22. 22

    Association of Cerebral Small Vessel Disease With Gait and Balance Disorders.

    Su C, Yang X, Wei S, Zhao R

    Frontiers in aging neuroscience 2022; (14()):834496 doi:10.3389/fnagi.2022.834496.

    PMID: 35875801
  23. 23

    A rare cause of monogenic cerebral small vessel disease and stroke: Cathepsin A-related arteriopathy with strokes and leukoencephalopathy (CARASAL).

    Budhdeo S, de Paiva ARB, Wade C, et al.

    Journal of neurology 2022; (269(12)):6673-6677 doi:10.1007/s00415-022-11302-9.

    PMID: 35904593
  24. 24

    Spatiotemporal gait characteristics during single- and dual-task walking are associated with the burden of cerebral small vessel disease.

    Xia C, Xie H, Li T, et al.

    Frontiers in neurology 2023; (14()):1285947 doi:10.3389/fneur.2023.1285947.

    PMID: 38020659
  25. 25

    Lysosomal sialidase NEU1, its intracellular properties, deficiency, and use as a therapeutic agent.

    Itoh K, Tsukimoto J

    Glycoconjugate journal 2023; (40(6)):611-619 doi:10.1007/s10719-023-10135-6.

    PMID: 38147151
  26. 26

    Human Genetics Society of Australasia Position Statement: Predictive and Presymptomatic Genetic Testing in Adults and Children.

    Vears DF, McLean A, La Spina C, et al.

    Twin research and human genetics : the official journal of the International Society for Twin Studies 2024; (27(2)):120-127 doi:10.1017/thg.2024.9.

    PMID: 38509872
  27. 27

    Role of Genetics in Diagnosis and Management of Hypertrophic Cardiomyopathy: A Glimpse into the Future.

    Abbas MT, Baba Ali N, Farina JM, et al.

    Biomedicines 2024; (12(3)) doi:10.3390/biomedicines12030682.

    PMID: 38540296
  28. 28

    Stroke.

    Hilkens NA, Casolla B, Leung TW, de Leeuw FE

    Lancet (London, England) 2024; (403(10446)):2820-2836 doi:10.1016/S0140-6736(24)00642-1.

    PMID: 38759664
  29. 29

    Clinical Reasoning: A 50-Year-Old Man With Intracerebral Hemorrhage and Tortuous Retinal Arterioles.

    Bouchart J, Weber S, Coste T, et al.

    Neurology 2024; (103(6)):e209796 doi:10.1212/WNL.0000000000209796.

    PMID: 39167747
  30. 30

    Monogenic causes of cerebral small vessel disease and stroke.

    Guey S, Chabriat H

    Handbook of clinical neurology 2024; (204()):273-287 doi:10.1016/B978-0-323-99209-1.00018-1.

    PMID: 39322384
  31. 31

    The experience of "at-risk" status for familial frontotemporal dementia (fFTD) and its impact on reproductive decision-making: A qualitative study.

    Fahy N, Hayes OS, Greaves CV, et al.

    Journal of genetic counseling 2025; (34(1)):e2000 doi:10.1002/jgc4.2000.

    PMID: 39801084
  32. 32

    Secondary stroke prevention beyond antiplatelets: The role of colchicine and GLP-1RA - an ounce of prevention is worth a pound of cure.

    Mijajlović MD, Bornstein NM, Aleksić V

    Therapeutic advances in neurological disorders 2025; (18()):17562864251326769 doi:10.1177/17562864251326769.

    PMID: 40291758
  33. 33

    Pediatric predictive testing to inform preimplantation genetic testing: A case report and review of the literature.

    Schaa KL, Thoeny R, Benson RJ, et al.

    Journal of genetic counseling 2025; (34(3)):e70053 doi:10.1002/jgc4.70053.

    PMID: 40372085
  34. 34

    Mechanistic advances in factors influencing phenotypic variability in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a review.

    Zhao Y, Lu Y, Wang F, et al.

    Frontiers in neurology 2025; (16()):1573052 doi:10.3389/fneur.2025.1573052.

    PMID: 40470487
  35. 35

    Assessment of Gait Disorders in Cerebral Small Vessel Disease: Advantages of Different Clinical Scales.

    Dobrynina LA, Bitsieva ET, Shamtieva KV, et al.

    Journal of clinical medicine 2025; (14(18)) doi:10.3390/jcm14186626.

    PMID: 41010830
  36. 36

    Lessons learned from 30 years of presymptomatic testing in Huntington Disease.

    Pierron L, Hébert M, Gargiulo M, Durr A

    Revue neurologique 2025; (181(9)):852-862 doi:10.1016/j.neurol.2025.07.009.

    PMID: 41238315
  37. 37

    Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP).

    Banach M, Toth PP, Ahn HJ, et al.

    Progress in cardiovascular diseases 2026; (94()):78-110 doi:10.1016/j.pcad.2025.11.003.

    PMID: 41249078
  38. 38

    Phenotypic Divergence in Siblings with the Same Genotype: Diffuse Dermal Melanocytosis in Infantile-Onset Galactosialidosis.

    Gürbüz BB, Özalp Ö

    Molecular syndromology 2026; (17(4)):409-416 doi:10.1159/000549013.

    PMID: 41409303
  39. 39

    Dysphagia and Dysarthria in Neurodegenerative Diseases: A Multisystem Network Approach to Assessment and Management.

    Fiorella ML, Ballini L, Lavermicocca V, et al.

    Audiology research 2026; (16(1)) doi:10.3390/audiolres16010009.

    PMID: 41562880
  40. 40

    Expanding the Clinicoradiologic Phenotype of the CTSA-Associated Small Vessel Disease CARASAL: A Comparison With CADASIL.

    Cerfontaine MN, Gravesteijn G, Hack RJ, et al.

    Neurology. Genetics 2026; (12(2)):e200358 doi:10.1212/NXG.0000000000200358.

    PMID: 41908989